Advertisement

Topics

Takeda San Francisco, Inc. Company Profile

23:05 EST 19th November 2017 | BioPortfolio

Takeda San Francisco, Inc. (TSF), established in November 2007 as a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Osaka, Japan, is Takeda's Biologics Center of Excellence and Antibody IND Engine for human antibody therapeutics for the treatment of cancer, inflammation and metabolic diseases. TSF supports Takeda's therapeutic antibody initiative in close collaboration with Takeda's other R&D organizations. Additional information about Takeda San Francisco is available at http://www.takedasf.com.


News Articles [547 Associated News Articles listed on BioPortfolio]

Takeda Strengthens its US Presence

Dr Greg Landes recently joined Takeda San Francisco as Vice President, Antibody Research where he is responsible for overseeing, and the management of, all research functions directed towards the disc...

Takeda and SGC Announce a Collaboration Agreement Using Patient Tissue-Based Assays for ...

For SGC and KI:Michael Sundström, Scientific DirectorMichael.sundstrom@ki.se+46 79 65 44 662KI press office: +46 8 524 860 77orFor Takeda:Tsuyoshi Tada – Japantsuyoshi.tada@takeda....

Takeda Research Investment: How Investments are Chosen

In this episode of PharmaTelevision News Review, Fintan Walton talks with Graeme Martin, President & CEO at Takeda Research Investment. Filmed at BioTrinity 2010 in Newbury, UK, they discuss: • TRI...

Takeda make a strategic acquisition

In this episode of PharmaTelevision News Review, Fintan Walton talks to Nigel Borshell, Director at PharmaVentures. Nycomed’s geographic presence in Europe and Emerging markets a strong justificati...

Takeda and Shattuck Labs Announce Research Collaboration to Explore Agonist Redirected ...

Takeda Contact:Kelly Schlemm – USAkelly.schlemm@takeda.com+1-617-551-8865orShattuck Contact:Josiah Hornblowerjhornblower@shattucklabs.com Read more...

Takeda options programs discovered through Schrodinger alliance

Takeda Pharmaceutical Co. Ltd. and drug discovery firm Schrodinger Inc. penned a multi-year, multi-target deal focused on Takeda’s core therapy areas.

Recursion, Takeda Ink $90 Million AI R&D Pact

Recursion Announces Research Collaboration with Takeda to Rapidly Build a Rare Disease PipelineCollaboration to leverage Recursion's AI-augmented phenotypic discovery platform, and Takeda's TAK-celera...

Takeda Ventures Inc: Graeme Martin. Extending Takeda’s reach into the Global scientific community

In this episode of PharmaTelevision News Review, filmed at BioTrinity 2013, Newbury UK, Fintan Walton speaks to Graeme Martin, President and CEO of Takeda Ventures Inc.

PubMed Articles [42 Associated PubMed Articles listed on BioPortfolio]

Trends in the San Francisco HIV Epidemic in the "Getting to Zero" Era.

San Francisco (SF) has launched interventions to reduce new HIV infections and HIV-associated morbidity and mortality during the SF "Getting to Zero (GTZ)" era. We measured recent changes in HIV care ...

Video Comment on Kenichi Takeda et al.

Deep nirS amplicon sequencing of San Francisco Bay sediments enables prediction of geography and environmental conditions from denitrifying community composition.

Denitrification is a dominant nitrogen loss process in the sediments of San Francisco Bay. In this study, we sought to understand the ecology of denitrifying bacteria by using next-generation sequenci...

Short-Term Effects of Early Switching to Ranibizumab or Aflibercept in Diabetic Macular Edema Cases With Non-Response to Bevacizumab.

To study the effect of early switching to ranibizumab (Lucentis; Genentech, South San Francisco, CA) or aflibercept (Eylea; Regeneron, Tarrytown, NY) in cases of diabetic macular edema (DME) that have...

Stable C and N isotope analysis of hair suggest undernourishment as a factor in the death of a mummified girl from late 19th century San Francisco, CA.

The chance discovery of a 1.5-3.5 years old mummified girl presents a unique opportunity to further our understanding of health and disease among children in 19th Century San Francisco. This study foc...

Clinical Trials [60 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Dexlansoprazole Capsules From Two Manufacturing Plants

The purpose of this study is to assess the bioavailability of dexlansoprazole from a 30 milligram (mg) or 60 mg delayed-release capsule manufactured at Takeda GmbH Plant Oranienburg, Germa...

Validation of the San Francisco Syncope Rule

This study was designed to validate the "San Francisco Syncope Rule". This set of rules was derived by Quinn et. al. to help guide the treatment of patients evaluated in the Emergency Dep...

A Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg Delayed Release (DR) Capsules (Takeda Pharmaceuticals America Inc., USA)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Dexlansoprazole from Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant...

The Stay Study: A Demonstration Project Advancing PrEP Delivery in the San Francisco Bay Area Transgender Community

The Stay Study is a multi-site, open-label HIV pre-exposure prophylaxis (PrEP) demonstration project for advancing PrEP delivery in the San Francisco Bay Area Transgender Community. Approx...

Evaluation of the Healthy Apple Program in San Francisco

This randomized controlled trial uses administrative public health screening data to test whether the Healthy Apple program (HAP), designed to support local implementation of national Let'...

Companies [491 Associated Companies listed on BioPortfolio]

Takeda San Francisco, Inc.

Takeda San Francisco, Inc. (TSF), established in November 2007 as a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Osaka, Japan, is Takeda's Biologics Center of Excellence and Antib...

Takeda San Francisco Inc.

Takeda San Francisco was established in November 2007 and supports Takeda's therapeutic antibody research aiming to build antibody technology platforms based on technologies such as discovery and ...

Takeda Pharmaceuticals International, Inc.

Located in Deerfield, Illinois, Takeda Pharmaceuticals International, Inc. is a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, an industry leader and the larges...

Takeda Oncology

Takeda Oncology, headquartered in Cambridge, MA, delivers novel medicines to patients with cancer worldwide through its commitment to science, breakthrough innovation and passion ...

Takeda Pharmaceuticals Company Limited

Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global lea...

More Information about "Takeda San Francisco, Inc." on BioPortfolio

We have published hundreds of Takeda San Francisco, Inc. news stories on BioPortfolio along with dozens of Takeda San Francisco, Inc. Clinical Trials and PubMed Articles about Takeda San Francisco, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Takeda San Francisco, Inc. Companies in our database. You can also find out about relevant Takeda San Francisco, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record